pH-Responsive Nanoparticles for Drug Delivery
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: closed (15 August 2023) | Viewed by 2523
Special Issue Editors
Interests: micelle; photo-immunotherapy; liposomes; drug delivery systems
Special Issues, Collections and Topics in MDPI journals
Interests: polymer nanoparticles; vascular nanomedicine; nanotoxicology; drug delivery systems
Special Issues, Collections and Topics in MDPI journals
Interests: nanoparticles; photothermal therapy; extracellular vesicles; cancer immunotherapies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Advancements in nanotechnology have led to intelligent drug delivery systems that can regulate the release of therapeutic cargo in a temporally, spatially, and stimuli-responsive manner. The efficacy of these intelligent nanoparticles can be enhanced by improving their responsiveness to external environmental stimuli, such as pH, redox potential, enzymatic activation, thermal gradients, magnetic fields, light, and ultrasound (US), and may favor targeted drug delivery. Of these various stimuli, the pH gradient has been widely explored as a tool to elicit the site-specific drug release at the organ, tissue, and sub-cellular levels by the tailored nanoparticles. Several research groups are actively investigating novel approaches in the design and engineering of pH-responsive nanoparticles to facilitate drug delivery. Henceforth, these continuous efforts promote the development of pH-responsive nanoparticles as potential nanomedicines for extensive biomedical applications. We welcome manuscripts focusing on pH-responsive nanoparticles that could improve precision therapy.
Dr. Saji Uthaman
Dr. Susheel Kumar Nethi
Dr. Kondareddy Cherukula
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
